Luminex Corporation (LMNX), a developer of biological testing technologies, has completed its previously-announced acquisition of privately-held diagnostic testing company EraGen Biosciences, Inc. for $34 million in cash. The companies struck a definitive agreement on June 21. Madison, Wisconsin-based EraGen, with annual sales of $8 million, makes molecular reagent products for infectious diseases and genetic-based conditions. [...] (LMNX) Luminex Wraps Up EraGen Buy